Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
Add more filters










Publication year range
1.
J Clin Endocrinol Metab ; 104(12): 5935-5947, 2019 12 01.
Article in English | MEDLINE | ID: mdl-31355884

ABSTRACT

CONTEXT: The pituitary-adrenal axis had historically been considered a representative model for circadian rhythms. A recently developed portable collection device has provided the opportunity to evaluate free cortisol profiles using the microdialysis approach in individuals free to conduct their day-to-day activities in their own surroundings. METHODS: Two separate experiments were conducted in healthy male volunteers. The total and subcutaneous (SC) free cortisol levels were measured at 10-minute intervals for a 24-hour period in one experiment, and the SC free cortisol levels were measured at 20-minute interval for 72 consecutive hours in free-living individuals in the second experiment. RESULTS: The characteristic circadian rhythm was evident in both serum total and SC free cortisol, with the lowest levels achieved and maintained in the hours surrounding sleep onset and the peak levels occurring in every individual around waking. In all free-living individuals, the circadian rhythm was consistent across the 72-hour period, despite a wide range of activities. All the participants also showed increased cortisol after the consumption of lunch. The lowest levels during all 24-hour periods were observed during the hours after lights off, at the onset of sleep. CONCLUSIONS: To the best of our knowledge, the present study is the first to report up to three consecutive 24-hour measurements of SC free cortisol in healthy individuals. We believe our study is a landmark study that paves the way for ambulatory monitoring of free cortisol profiles continuously for a period of 72 hours in free-living individuals performing their day-to-day activities whether healthy or with diseases involving the hypothalamic-pituitary-adrenal axis.


Subject(s)
Circadian Rhythm/physiology , Hydrocortisone/analysis , Time Factors , Adolescent , Healthy Volunteers , Humans , Hypothalamo-Hypophyseal System/metabolism , Male , Monitoring, Physiologic/methods , Pituitary-Adrenal System/metabolism , Sleep/physiology , Young Adult
2.
J Med Eng Technol ; 37(3): 180-4, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23547774

ABSTRACT

Hormonal systems are major regulators of metabolic and cognitive function and many of these, including the critical stress-responsive hypothalamic-pituitary-adrenal (HPA) axis, release their constituent hormones in a circadian manner. This circadian rhythmicity is made up from an underlying approximate hourly ultradian rhythm. In order to understand the importance of both circadian and ultradian rhythms in man it is important to be able to carry out multiple sampling studies over extended periods in a subject's home setting, which is the most meaningful physiological setting for homeostatically important hormones. This study has developed a novel automated sampling system that, when used in combination with a microdialysis system, collects timed samples of microdialysis fluid over a full 24 h in individuals going about their normal everyday activity. The apparatus has the capacity to provide sufficient sample volumes to measure changes in hormone concentration over 24 h, including the important period when subjects are asleep.


Subject(s)
Hydrocortisone/metabolism , Subcutaneous Tissue/metabolism , Abdomen , Adolescent , Circadian Rhythm/physiology , Enzyme-Linked Immunosorbent Assay , Humans , Male , Microdialysis/methods , Young Adult
3.
J Psychopharmacol ; 24(5): 745-56, 2010 May.
Article in English | MEDLINE | ID: mdl-18801833

ABSTRACT

Voluntary exercise improves stress coping and lowers anxiety. Because of the role of GABA in these processes, we investigated changes in the central GABAergic system in rats with free access to a running wheel for 4 weeks. The control animals had no access to a running wheel. Using insitu hybridisation histochemistry, we studied changes in gene expression of various GABA(A) receptor subunits as well as the GABA-synthesising enzyme glutamic acid decarboxylase-67 (GAD67) in the forebrain. There were region-specific decreases in alpha2, beta3 and gamma2 subunit mRNA expression and region-specific increases in beta1 subunit expression. The alpha5 and delta subunits, in the forebrain specifically associated with extrasynaptic GABA(A) receptors in the hippocampus, showed differential increases in expression levels. Expression of GAD67 mRNA was increased in many forebrain regions including all hippocampal cell layers, peri-paraventricular nucleus, bed nucleus stria terminalis, nucleus accumbens core and motor cortex, suggesting that long-term voluntary exercise enhances forebrain GABA synthesis capacity but in a region-specific manner. Thus, regular performance of exercise results in extensive changes in the forebrain GABAergic system that may be implicated in the changes in stress sensitivity and emotionality observed in exercising subjects.


Subject(s)
Behavior, Animal/physiology , Gene Expression Regulation , Glutamate Decarboxylase/genetics , Physical Exertion , Prosencephalon/metabolism , Receptors, GABA-A/genetics , Animals , Glutamate Decarboxylase/metabolism , In Situ Hybridization , Male , Motor Activity , Organ Specificity , Prosencephalon/cytology , Protein Subunits/genetics , Protein Subunits/metabolism , RNA, Messenger , Rats , Rats, Sprague-Dawley , Receptors, GABA-A/metabolism
4.
J Neuroendocrinol ; 21(2): 132-40, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19076270

ABSTRACT

Recently, we described that free corticosterone levels in the brain of male Wistar rats, as assessed by in vivo microdialysis, show an ultradian rhythm with a pulse frequency of 1.2 pulses/h. To establish whether gender influences brain free corticosterone rhythms, we studied free corticosterone levels in the female Wistar rat under baseline and stressful conditions using microdialysis in the hippocampus. Analysis of the data with the PULSAR algorithm revealed that hippocampal free corticosterone levels show a clear ultradian pattern in female rats with a pulse frequency of 1.16+/-0.05 pulses/h between 09.00 h and 21.00 h. Further analysis showed that the pulse amplitude is significantly higher during the late afternoon/early night (15.00-21.00 h) than during the morning/early afternoon (09.00-15.00 h) phase (0.13+/-0.03 versus 0.07+/-0.01 microg/dl, respectively, P < 0.05). Pulse characteristics were extremely reproducible as demonstrated by the almost identical pulse parameters derived from two consecutive 24-h periods [pulse frequency: 1.13+/-0.09 and 1.19+/-0.08 pulses/h; pulse amplitude: 0.11+/-0.05 and 0.10+/-0.02 microg/dl for day 1 and day 2 (09.00-21.00 h) respectively, P > 0.05]. Both exposure to a novel environment and forced swim stress increased hippocampal free corticosterone levels. However, the stress-induced rise reached higher levels and was more prolonged after forced swimming (area under the curve: 46.84+/-9.25 and 12.08+/-1.69 arbitrary units for forced swimming and novelty stress respectively, P = 0.01). Importantly, the ultradian rhythm was rapidly restored after termination of the stress response. This is the first demonstration that the female rat brain is exposed to free corticosterone levels that follow a circadian as well as an ultradian pattern and show almost identical pulse characteristics as recently reported in male animals. These observations are of significance for further investigations into the dynamics of glucocorticoid action in the brain of both genders.


Subject(s)
Brain/metabolism , Circadian Rhythm/physiology , Corticosterone/metabolism , Rats, Wistar/physiology , Algorithms , Animals , Environment , Female , Hippocampus/cytology , Hippocampus/metabolism , Humans , Male , Microdialysis , Photoperiod , Rats , Sex Factors , Stress, Psychological , Swimming
5.
Neuroscience ; 148(3): 794-805, 2007 Sep 07.
Article in English | MEDLINE | ID: mdl-17693036

ABSTRACT

In the hippocampus, a brain structure critically important in the stress response, GABA controls neuronal activity not only via synaptic inhibition, but also via tonic inhibition through stimulation of extrasynaptic GABA receptors. The extracellular level of GABA may represent a major determinant for tonic inhibition and, therefore, it is surprising that its responsiveness to stress has hardly been investigated. To clarify whether hippocampal extracellular GABA levels change in response to acute stress, we conducted an in vivo microdialysis study in rats. We found that dialysate GABA levels respond to various neuropharmacological manipulations such as reuptake inhibition, elevated concentrations of K(+), tetrodotoxin and baclofen, indicating that a large proportion of hippocampal extracellular GABA depends on neuronal release and that GABA re-uptake plays a role in determining the extracellular levels of this neurotransmitter. Next, rats were exposed to a novel cage or to forced swimming in 25 degrees C water. Interestingly, these two stressors resulted in opposite effects. Novelty caused a fast increase in GABA (120% of baseline), whereas forced swimming resulted in a profound decrease (70% of baseline). To discriminate between the psychological and physical aspects (i.e. the effects on body temperature) of forced swimming, another group of animals was forced to swim at 35 degrees C. This stressor, like novelty, caused an increase in hippocampal GABA, suggesting a stimulatory effect of psychological stress. The effects of novelty could not be blocked by the corticotropin-releasing factor receptor antagonist D-Phe-CRF(12-41). These results are the first to demonstrate stressor-dependent changes in hippocampal extracellular GABA; an observation which may be of particular significance for GABAergic tonic inhibition of hippocampal neurons.


Subject(s)
Exploratory Behavior/physiology , Hippocampus/metabolism , Neural Inhibition/physiology , Neurons/metabolism , Stress, Psychological/metabolism , gamma-Aminobutyric Acid/metabolism , Animals , Body Temperature/physiology , Corticosterone/metabolism , Corticotropin-Releasing Hormone/metabolism , Extracellular Fluid/metabolism , Fear/physiology , GABA Agonists/pharmacology , Male , Microdialysis , Potassium/metabolism , Potassium/pharmacology , Rats , Rats, Wistar , Receptors, Corticotropin-Releasing Hormone/antagonists & inhibitors , Receptors, Corticotropin-Releasing Hormone/metabolism , Sodium Channel Blockers/pharmacology , Stress, Psychological/physiopathology , Swimming/physiology , Synaptic Transmission/drug effects , Synaptic Transmission/physiology
6.
Handb Exp Pharmacol ; (169): 181-204, 2005.
Article in English | MEDLINE | ID: mdl-16594259

ABSTRACT

The amount of evidence for a role of aberrant serotoninergic neurotransmission in the aetiology of anxiety disorders, such as generalised anxiety and panic disorder, has been increasing steadily during the past several years. Although the picture is far from complete yet--partly due to the large number of serotonin (5-HT) receptors and the often-disparate effects of receptor agonists and antagonists in animal models of anxiety--SSRIs and the 5-HT1A agonist buspirone have now earned their place in the treatment of anxiety disorders. However, these drugs show--as they do in depressed patients--a delayed onset of improvement. Therefore, new therapeutical strategies are being explored. Corticotropin-releasing hormone (CRH), which plays a key role in the autonomic, neuroendocrine and behavioural responses to stress, is a strong anxiogenic neuropeptide and a promising candidate for therapeutical intervention in anxiety disorders. The neuroanatomical localisation of CRH, its congeners (the urocortins) and their receptors within the serotoninergic raphé nuclei suggests that interactions between the CRH system and 5-HT may play a role in fear and anxiety. In this chapter, I will discuss studies from my own and other laboratories showing that CRH and the urocortins influence several aspects of serotoninergic neurotransmission, including the firing rate of 5-HT neurones and the release and synthesis of this monoamine. Moreover, the interactions between CRH and 5-HT during psychologically stressful challenges will be discussed. Finally, I will review data showing that long-term alterations in the CRH system lead to aberrant functioning of serotoninergic neurotransmission under basal and/or stressful conditions. From this growing set of data the picture is emerging that the CRH system exerts a vast modulatory influence on 5-HT neurotransmission. An aberrant cross-talk between CRH and 5-HT may be of crucial importance in the neurobiology of anxiety disorders and represents, therefore, a promising goal for therapeutical intervention in these psychiatric diseases.


Subject(s)
Anxiety Disorders/etiology , Anxiety Disorders/therapy , Corticotropin-Releasing Hormone/physiology , Serotonin/physiology , Animals , Anxiety Disorders/physiopathology , Corticotropin-Releasing Hormone/administration & dosage , Hippocampus/physiopathology , Humans , Mice , Microdialysis , Synaptic Transmission
7.
Neuroscience ; 109(2): 253-66, 2002.
Article in English | MEDLINE | ID: mdl-11801362

ABSTRACT

Corticotropin-releasing hormone plays an important role in the coordination of various responses to stress. Previous research has implicated both corticotropin-releasing hormone and the serotonergic system as causative factors in the development and course of stress-related psychiatric disorders such as major depression. To delineate the role of the corticotropin-releasing hormone receptor type 1 (CRH-R1) in the interactions between corticotropin-releasing hormone and serotonergic neurotransmission, in vivo microdialysis was performed in CRH-R1-deficient mice under basal (home cage) and stress (forced swimming) conditions. Hippocampal dialysates were used to measure extracellular levels of serotonin and its metabolite 5-hydroxyindoleacetic acid, and free corticosterone levels to monitor the status of the hypothalamic-pituitary-adrenocortical axis. Moreover, behavioural activity was assessed by visual observation and a scoring paradigm. Both wild-type and heterozygous mutant mice showed a clear diurnal rhythm in free corticosterone. Free corticosterone concentrations were, however, lower in heterozygous mutant mice than in wild-type animals and undetectable in homozygous CRH-R1-deficient mice. Homozygous CRH-R1-deficient mice showed enhanced hippocampal levels of 5-hydroxyindoleacetic acid but not of serotonin during the light and the dark phase of the diurnal cycle, which may point to an enhanced synthesis of serotonin in the raphe-hippocampal system. Moreover, the mutation resulted in higher behavioural activity in the home cage during the light but not during the dark period. Forced swimming caused a rise in hippocampal serotonin followed by a further increase after the end of the stress paradigm in all genotypes. Homozygous and heterozygous mutant mice showed, however, a significantly amplified serotonin response to the forced swimming as compared to wild-type control animals. We conclude that CRH-R1-deficiency results in reduced hypothalamic-pituitary-adrenocortical axis activity, in enhanced synthesis of serotonin during basal conditions, and in an augmented response in extracellular levels of serotonin to stress. These data provide further evidence for the intricate relationship between corticotropin-releasing hormone and serotonin and the important role of the CRH-R1 herein.


Subject(s)
Corticotropin-Releasing Hormone/metabolism , Hippocampus/metabolism , Receptors, Corticotropin-Releasing Hormone/deficiency , Serotonin/metabolism , Stress, Physiological/metabolism , Synaptic Transmission/genetics , Animals , Behavior, Animal/physiology , Circadian Rhythm/genetics , Cortisone/metabolism , Extracellular Space/metabolism , Hydroxyindoleacetic Acid/metabolism , Hypothalamo-Hypophyseal System/metabolism , Male , Mice , Mice, Mutant Strains , Microdialysis , Receptors, Corticotropin-Releasing Hormone/genetics , Stress, Physiological/physiopathology , Swimming/physiology
8.
J Neurosci ; 21(13): 4822-9, 2001 Jul 01.
Article in English | MEDLINE | ID: mdl-11425909

ABSTRACT

We investigated whether acute stressors regulate functional properties of the hippocampal mineralocorticoid receptor (MR), which acts inhibitory on hypothalamic-pituitary-adrenocortical activity. Exposure of rats to forced swimming or novelty evoked a significant rise in density of MR immunoreactivity in all hippocampal subfields after 24 hr, whereas exposure to a cold environment was ineffective. Time course analysis revealed that the effect of forced swimming on MR peaked at 24 hr and returned to control levels between 24 and 48 hr. In pyramidal neurons of CA2 and CA3, marked rises were already observed after 8 hr. Radioligand binding assays showed that corticotropin-releasing hormone (CRH) injected intracerebroventricularly into adrenalectomized rats also produced a rise in hippocampal MR levels; an effect for which the presence of corticosterone, but not dexamethasone, at the time of injection was a prerequisite. Moreover, pretreatment with the CRH receptor antagonist (d-Phe(12),Nle(21,38),alpha-Me-Leu(37))-CRH(12-41) blocked the effect of forced swimming on hippocampal MR levels. To investigate whether the rise in MR levels had any functional consequences for HPA regulation, 24 hr after forced swimming, a challenge test with the MR antagonist RU 28318 was conducted. The forced swimming exposed rats showed an enhanced MR-mediated inhibition of HPA activity. This study identifies CRH as an important regulator of MR, a pathway with marked consequence for HPA axis regulation. We conclude that the interaction between CRH and MR presents a novel mechanism involved in the adaptation of the brain to psychologically stressful events.


Subject(s)
Corticotropin-Releasing Hormone/metabolism , Hippocampus/physiopathology , Receptors, Mineralocorticoid/metabolism , Stress, Psychological/physiopathology , Adrenalectomy , Animals , Cold Temperature , Corticosterone/pharmacology , Corticotropin-Releasing Hormone/administration & dosage , Corticotropin-Releasing Hormone/analogs & derivatives , Corticotropin-Releasing Hormone/pharmacology , Dexamethasone/pharmacology , Environment , Glucocorticoids/metabolism , Hippocampus/cytology , Hippocampus/drug effects , Hypothalamo-Hypophyseal System/physiopathology , Immunohistochemistry , Injections, Intraventricular , Male , Mineralocorticoid Receptor Antagonists/pharmacology , Peptide Fragments/pharmacology , Pituitary-Adrenal System/physiopathology , Pyramidal Cells/cytology , Pyramidal Cells/drug effects , Pyramidal Cells/metabolism , Radioligand Assay , Rats , Rats, Wistar , Receptors, Corticotropin-Releasing Hormone/antagonists & inhibitors , Receptors, Glucocorticoid/metabolism , Spironolactone/analogs & derivatives , Spironolactone/pharmacology , Swimming
9.
Neuroendocrinology ; 73(2): 139-48, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11244301

ABSTRACT

Glucocorticoids inhibit stimulus-induced T-cell proliferation, an early and essential parameter of cellular immunity. It was recently found however that physiological concentrations of glucocorticoids can also accelerate, not only inhibit, rat T-cell mitogenesis. We investigated mechanism(s) underlying mitogenic actions of glucocorticoids on anti-T-cell receptor (TCR)- and concanavalin A (Con A)-induced T-cell proliferation. Surprisingly, the ability of the glucocorticoid corticosterone (CORT) to either enhance or inhibit T-cell proliferation was found to depend primarily on the cell density and the timing of the cultures. At cell densities up to 1 x 10(5) cells/well (i.e. 'low' density), CORT inhibited T-cell proliferation irrespective of the culture time. In contrast, at cell densities of 2 x 10(5) cells/well and higher ('high' density), CORT potently stimulated T-cell mitogenesis during the first 2-3 culture days, but subsequently inhibited the proliferative response after 5-7 days. The glucocorticoid receptor antagonist RU486 completely abolished the effects of CORT. However, production of the main T cell growth factor interleukin (IL)-2 was inhibited by CORT at both 'low' and 'high' cell densities. In addition, irrespective of cell density, T-cell mitogenesis under either control conditions or in presence of CORT was completely blocked by an anti-IL-2-receptor-alpha-chain (IL-2Ralpha) antibody, indicating that T-cell proliferation was dependent on the IL-2 pathway. Immunofluorescence staining of IL-2Ralpha on CD4+ cells after 2-3 days in culture was increased by CORT, but only on cells cultured at 'high' density. Thus, glucocorticoids increase T-cell responsiveness to IL-2 under conditions of 'high' cell density only. We conclude that glucocorticoids may contribute to a more efficient early stage of cellular immune responses under conditions of intimate cell-to-cell contact (i.e. 'high' cell density), a situation likely to be present in vivo, for instance in lymph nodes. Thus, these findings are relevant to our understanding of the glucocorticoid control of immune function.


Subject(s)
Corticosterone/pharmacology , Lymphocyte Activation/drug effects , Spleen/cytology , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , Animals , Antibodies, Monoclonal/pharmacology , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/immunology , Cell Count , Cells, Cultured , Concanavalin A/pharmacology , Corticosterone/administration & dosage , Dose-Response Relationship, Drug , Male , Rats , Rats, Wistar , Receptors, Antigen, T-Cell/immunology , Receptors, Antigen, T-Cell, alpha-beta/immunology , Time Factors
10.
Eur J Pharmacol ; 405(1-3): 235-49, 2000 Sep 29.
Article in English | MEDLINE | ID: mdl-11033331

ABSTRACT

Glucocorticoids exert their regulatory effects on the hypothalamic-pituitary-adrenocortical axis via two types of corticosteroid receptors: the glucocorticoid receptor and the mineralocorticoid receptor. Whereas the glucocorticoid receptor has a broad distribution in the brain, highest levels of mineralocorticoid receptor are found in the hippocampus. Based on the differential occupancy profile by endogenous glucocorticoids, glucocorticoid receptors are thought to mediate negative feedback signals of elevated glucocorticoid levels, whereas mineralocorticoid receptors control the inhibitory tone of the hippocampus on hypothalamic-pituitary-adrenocortical axis activity. Dysfunction of mineralocorticoid receptors and glucocorticoid receptors are thought to be implicated in stress-related psychiatric diseases such as major depression. Because of its intriguing features, we focus in this review on the mineralocorticoid receptor and provide data which reveal novel aspects of the pharmacology and physiology of mineralocorticoid receptors. Newly obtained results are presented, which help to solve the paradox of why dexamethasone binds with high affinity to mineralocorticoid receptors in vitro, yet binds poorly in vivo. Until recently, mineralocorticoid receptor protein and mRNA levels could only be routinely studied with in vitro cytosol binding assays, in vitro and in vivo receptor autoradiography, Northern blot analysis, and in situ hybridization. These methods are unfortunately hampered by several flaws, such as the necessity of adrenalectomy, no or poor neuroanatomical resolution, the fact that mRNA does not provide the same information as protein, or combinations of these factors. We present immunohistochemical data on mineralocorticoid receptors in the brain obtained by using commercially available antibodies, which alleviate many of these shortcomings. Furthermore, an in vivo microdialysis method is presented which allows the assessment of free corticosterone levels in the brain, which is critical for the study of the pharmacological basis of mineralocorticoid receptor (and glucocorticoid receptor) function. Finally, a novel aspect of the regulation of mineralocorticoid receptors is described which provides evidence that this receptor system is dynamically regulated. In conjunction with previously reported effects of antidepressants, these results have initiated a new concept on the cause of the hypothalamic-pituitary-adrenocortical axis disturbances often seen in stress-related psychiatric disorders such as major depression.


Subject(s)
Brain Chemistry/physiology , Receptors, Mineralocorticoid/physiology , Animals , Humans , Ligands , Receptors, Mineralocorticoid/metabolism
11.
Neuroendocrinology ; 71(6): 375-85, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10878499

ABSTRACT

Inoculation of rats with microorganisms or microbial constituents that activate host defense promotes non-rapid eye movement sleep (non-REMS) and suppresses REMS. In this study, we evaluated circadian influences on the effects of lipopolysaccharide (LPS) on sleep, sickness behavior and plasma corticosterone levels in the rat. Three sets of experiments were performed. In each, the animals were intraperitoneally injected with vehicle for LPS (30 microg/kg) during 2 consecutive days, at the beginning of either the circadian rest or the activity phase. In experiment 1, sleep-wake behavior and brain temperature were recorded, and in experiment 2, core body temperature, locomotor activity as well as food and water intake. In experiment 3, corticosterone blood levels were measured. The results show that LPS-evoked changes in temperature, sleep and other behavioral parameters depend markedly on the time of day LPS is administered. However, a direct comparison of the LPS data demonstrates that, except for sleep parameters, the absolute time course of the assessed parameters was rather similar between the rest and activity phases. These findings suggest that LPS evokes a state characterized by high temperature and low vigilance, which is reached independently of the circadian phase.


Subject(s)
Behavior, Animal/drug effects , Circadian Rhythm/physiology , Corticosterone/blood , Lipopolysaccharides/pharmacology , Sleep/drug effects , Animals , Arousal/drug effects , Body Temperature/drug effects , Body Temperature/physiology , Brain/drug effects , Brain/physiology , Drinking/drug effects , Eating/drug effects , Electroencephalography/drug effects , Male , Motor Activity/drug effects , Rats , Rats, Wistar , Sleep, REM/drug effects
12.
Pharmacol Biochem Behav ; 66(1): 143-51, 2000 May.
Article in English | MEDLINE | ID: mdl-10837854

ABSTRACT

Long-term voluntary alcohol drinking with repeated alcohol deprivation episodes has been suggested as animal model for some aspects of alcoholism. Using a radiotelemetric system, the present study investigated the occurrence of withdrawal symptoms in long-term voluntarily alcohol drinking Wistar rats with (repeated alcohol deprivation group) and without (first alcohol deprivation group) prior alcohol deprivation experience. Six days after transmitter implantation, alcohol bottles were removed, and returned 4 days later. Alcohol deprivation induced hyperlocomotion in both groups. In the repeated alcohol deprivation group, hyperlocomotion was increased at the beginning of the alcohol deprivation phase and decreased during the following dark phase, suggesting that removal of the alcohol bottles might have become a conditioned withdrawal stimulus for this group. Both groups showed an enhanced alcohol intake after representation of alcohol bottles compared to preabstinence intakes (alcohol deprivation effect). However, alcohol intake of the repeated alcohol deprivation group was significantly increased compared to the first alcohol deprivation group at the end of the experiment. It is concluded that repeated alcohol deprivation experience might promote the development of alcohol addiction because of its latent stimulating effect on alcohol drinking that can be unveiled by (presumably mildly stressful) experimental situations.


Subject(s)
Alcohol Drinking , Substance Withdrawal Syndrome/psychology , Alcohol Drinking/psychology , Animals , Body Temperature/drug effects , Eating , Male , Motor Activity/drug effects , Rats , Rats, Wistar
13.
Eur J Neurosci ; 12(1): 283-91, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10651883

ABSTRACT

To study the consequences of impaired functioning of the glucocorticoid receptor (GR) for behavioural, neuroendocrine and neurochemical responses to a psychological stressor, a transgenic mouse expressing antisense RNA against GR was used. Previous studies on these transgenic mice have shown that impairment of GR evolves in disturbed neuroendocrine regulation and certain behavioural responses to stress. Here we investigated putative disturbances on the level of brain neurotransmission in GR-impaired (GR-i) mice using an in vivo microdialysis method. Through a microdialysis probe in the hippocampus, serotonin (5-HT), 5-hydroxyindoleacetic acid (5-HIAA) and free corticosterone [as an index of hypothalamic-pituitary-adrenocortical (HPA) axis activity] were monitored. Moreover, specific behaviours (e.g. grooming, eating/drinking, sniffing, nest building and locomotion) displayed by the mice during collection of the dialysates were scored. Measurement of dialysate concentrations of corticosterone on days 1 and 3 after insertion of the microdialysis probe showed that the free levels of this glucocorticoid were significantly lower in GR-i mice toward the evening. On day 2 after insertion of the microdialysis probe, baseline values of dialysate corticosterone, 5-HT and 5-HIAA were assessed, after which mice were exposed to a rat placed into their home cage. The rat and mouse were separated by a Plexiglas wall. A positive correlation between baseline hippocampal extracellular levels of 5-HT and 5-HIAA and the time spent performing active behaviours was observed in both genotypes. The main active behaviour performed at the baseline was grooming behaviour. During the rat exposure period, control mice remained mostly sitting and/or lying with their eyes fixed on the rat. Moreover, they showed a profound rise in free corticosterone levels. In contrast, GR-i mice displayed significantly more activities along the separation wall and a trend toward more grooming behaviour, but no increase of free corticosterone. In both mouse lines, exposure to a rat increased hippocampal extracellular levels of 5-HT and 5-HIAA. The rise in 5-HT was, however, more pronounced in the GR-i mice. From these data it may be concluded that life-long GR impairment has profound consequences for behavioural and neuroendocrine responses to a psychological stressor. Moreover, long-term impaired functioning of GR evolves in hyper-responsiveness of the raphe-hippocampal serotonergic system.


Subject(s)
Behavior, Animal , Hippocampus/metabolism , Receptors, Glucocorticoid/genetics , Receptors, Glucocorticoid/physiology , Stress, Psychological/physiopathology , Animals , Corticosterone/metabolism , Drinking Behavior , Feeding Behavior , Grooming , Hydroxyindoleacetic Acid/metabolism , Hypothalamo-Hypophyseal System/physiology , Male , Mice , Mice, Inbred Strains , Mice, Transgenic , Microdialysis , Motor Activity , Pituitary-Adrenal System/physiology , Promoter Regions, Genetic , RNA, Antisense , Rats , Serotonin/metabolism , Stress, Psychological/genetics , Time Factors
14.
Z Rheumatol ; 59 Suppl 2: II/22-5, 2000.
Article in English | MEDLINE | ID: mdl-11155799

ABSTRACT

Two types of corticosteroid receptors have been identified in the brain and pituitary that play an important role in the regulation of the hypothalamic-pituitary-adrenocortical (HPA) axis. These glucocorticoid hormone binding receptors are the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR). Evidently, a tight control of the concentration and function of these receptors is of prime importance for maintaining and regaining homeostasis after stressful challenges. Here, we describe a novel mechanism revealing a rapid upsurge in MR density in the hippocampus (a limbic structure highly involved in HPA axis regulation) after an acute psychologically stressful challenge. This rise in MR is accompanied by a stronger MR-mediated inhibitory control of the HPA axis. Thus, an acute stressful experience results in a reorganization of the HPA axis involving a principal role of the hippocampal MR. This novel mechanism may be of significance for increasing our understanding of the etiology of stress-related disorders.


Subject(s)
Hypothalamo-Hypophyseal System/physiopathology , Pituitary-Adrenal System/physiopathology , Receptors, Glucocorticoid/physiology , Receptors, Mineralocorticoid/physiology , Animals , Brain Mapping , Corticotropin-Releasing Hormone/physiology , Hippocampus/physiopathology , Humans , Rats , Up-Regulation/physiology
16.
Eur J Neurosci ; 11(1): 178-86, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9987022

ABSTRACT

The consequences of glucocorticoid receptor (GR) dysfunction for neuroimmunoendocrine responses to an inflammatory challenge were studied in transgenic mice expressing antisense RNA directed against the GR [GR-impaired (GR-i) mice]. Mice were implanted intraperitoneally with a biotelemetry transmitter to monitor body temperature and locomotion. GR-i mice showed decreased locomotion and body temperature during the dark phase of the diurnal cycle. Intraperitoneal administration of saline caused a rapid increase in body temperature in control mice, which was terminated within 90 min. In GR-i mice, however, body temperature remained elevated for about 6 h. Intraperitoneal injection of endotoxin (10 micrograms/mouse) produced a biphasic fever in control mice. However, in endotoxin-injected GR-i mice, body temperature was not significantly different from their saline-injected controls during the first 6 h. Body temperature then increased and remained elevated during the night period. Both strains showed hypolocomotion after endotoxin. In a second experiment, mice were injected intraperitoneally with saline or endotoxin and killed after 1, 3, 6 or 24 h. In GR-i mice, endotoxin caused an augmented rise in plasma ACTH, but not in corticosterone levels. The endotoxin-induced increase in serum levels of interleukin-1 beta and interleukin-6 was not different between the strains. However, whereas in control mice tumour necrosis factor-alpha levels were below detection at the time points studied, substantial levels of this cytokine were found in the serum of GR-i mice 1 h after endotoxin administration. It may be concluded that life-long impairment of GR evolves in aberrant physiological and humoral responses to an acute inflammatory challenge. These findings expand our understanding about the neuroendocrine and physiological disturbances associated with stress-related disorders.


Subject(s)
Lipopolysaccharides/pharmacology , Neurosecretory Systems/chemistry , Neurosecretory Systems/physiopathology , Receptors, Glucocorticoid/genetics , Receptors, Glucocorticoid/metabolism , Adrenocorticotropic Hormone/blood , Animals , Antisense Elements (Genetics) , Behavior, Animal/drug effects , Body Temperature/drug effects , Circadian Rhythm/physiology , Corticosterone/blood , Injections, Intraperitoneal , Interleukin-1/metabolism , Interleukin-6/metabolism , Locomotion/drug effects , Male , Mice , Mice, Transgenic , Neurosecretory Systems/drug effects , Promoter Regions, Genetic/physiology , Sodium Chloride/pharmacology , Transgenes/physiology , Tumor Necrosis Factor-alpha/metabolism
17.
Neuropsychopharmacology ; 19(5): 381-96, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9778660

ABSTRACT

Two Wistar rat lines, selectively bred for high-anxiety-related behavior (HAB) and low-anxiety-related behavior (LAB) in the elevated plus-maze test, were tested for the susceptibility of their behavioral characteristics to anxiolytic treatment and for their endocrine and physiological reactivity to different stressors. Injection of 1 mg/kg diazepam failed to affect line differences in coping strategy but resulted in a marked (20-fold) decrease in plus-maze anxiety in HAB rats; whereas, the anxiolytic effect was less pronounced in LAB animals. Biotelemetrical measurements revealed that HAB and LAB rats do not significantly differ in their baseline body temperature, locomotor activity, food and water intake, or in stress-induced alterations of the diurnal rhythms in these parameters. However, line differences were found in acute changes in body temperature and locomotor activity following stress exposure, LAB rats responding with a greater, albeit shorter, increase in body temperature and activity than HAB animals. Basal ACTH and corticosterone plasma levels as well as pituitary reactivity to intravenously administered CRH (40 ng/kg) were similar in both lines, although, especially in response to plus-maze exposure, HAB rats tended toward higher ACTH secretion than LAB rats. These data confirm that animals with high or low basal levels of anxiety may be a promising model for studying the mechanisms of action of anxiolytic substances. Nevertheless, the endocrine findings support the notion that the reactivity of the hypothalamo-pituitary-adrenocortical system and anxiety-related behavior can be regulated independently.


Subject(s)
Adrenocorticotropic Hormone/blood , Anti-Anxiety Agents/pharmacology , Anxiety , Corticosterone/blood , Diazepam/pharmacology , Motor Activity/drug effects , Animals , Anxiety/genetics , Male , Rats , Rats, Wistar , Stress, Physiological/blood
18.
Eur J Neurosci ; 10(3): 868-78, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9753154

ABSTRACT

Intraperitoneal endotoxin injection and central administration of interleukin (IL)-1beta profoundly activate hippocampal serotonergic neurotransmission. This study was designed to investigate, using in vivo microdialysis, the effects of another endotoxin-induced proinflammatory cytokine, tumour necrosis factor-alpha, and the effects of the non-inflammatory cytokine, IL-2, on hippocampal extracellular levels of serotonin. To compare the effects of these cytokines on neurotransmission with the effects on physiological parameters and behaviour, hypothalamic-pituitary-adrenocortical (HPA) axis activity, body temperature and behavioural activity were monitored as well. Time-dependent changes in serotonergic neurotransmission and HPA axis activity were determined by measuring serotonin, its metabolite 5-hydroxyindoleacetic acid and free corticosterone in dialysates. Total behavioural activity was scored by assessing the time during which rats were active. Core body temperature was measured by biotelemetry. Intracerebroventricular injection of 50 or 100 ng recombinant murine tumour necrosis factor-alpha exerted no effect on hippocampal serotonergic neurotransmission, and induced no signs of sickness behaviour. However, these doses produced a dose-dependent increase in body temperature and free corticosterone levels. In contrast, intracerebroventricular administration of 500 ng, but not of 50 ng, recombinant human IL-2 produced a marked increase in hippocampal extracellular concentrations of serotonin and 5-hydroxyindoleacetic acid, accompanied by a pronounced behavioural inhibition and other signs of sickness. Moreover, both doses of IL-2 caused a dose-dependent increase in body temperature and free corticosterone levels. Interestingly, intracerebroventricular pretreatment with the IL-1 receptor antagonist showed that the effects of IL-2 on hippocampal serotonin were completely dependent on endogenous brain IL-1. However, IL-1 seemed to play only a minor role in the IL-2-induced increase in free corticosterone. Taken together, the results show that cytokines produce partially overlapping brain-mediated responses, but are selectively effective in stimulating hippocampal serotonergic neurotransmission and inducing sickness behaviour. Moreover, we postulate that activation of hippocampal serotonin release is instrumental in the full development of behavioural inhibition.


Subject(s)
Behavior, Animal/drug effects , Body Temperature/drug effects , Hippocampus/physiology , Hypothalamo-Hypophyseal System/drug effects , Interleukin-2/pharmacology , Pituitary-Adrenal System/drug effects , Serotonin/physiology , Synaptic Transmission/drug effects , Tumor Necrosis Factor-alpha/pharmacology , Animals , Body Temperature/physiology , Brain Chemistry/drug effects , Corticosterone/blood , Hippocampus/drug effects , Humans , Male , Microdialysis , Motor Activity/drug effects , Rats , Rats, Wistar , Synaptic Transmission/physiology
19.
Ann N Y Acad Sci ; 840: 139-52, 1998 May 01.
Article in English | MEDLINE | ID: mdl-9629246

ABSTRACT

It is now well established that an inflammatory challenge as evoked by bacterial endotoxin (LPS) induces autonomic, endocrine, and behavioral responses that are controlled by the brain. However, detailed information on the neuronal pathways and neurotransmitters involved is scarce. We used in vivo microdialysis and biotelemetry in rats to monitor hippocampal and preoptic serotonergic and noradrenergic neurotransmission, body temperature, and heart rate after an i.p. LPS injection. Moreover, free corticosterone levels were measured in the dialysates, and behavioral activity was scored by visual observation. Apart from a biphasic fever response, tachycardia, elevated free corticosterone levels, and sickness behavior, peripheral injection of LPS caused a dramatic increase in preoptic extracellular concentrations of noradrenaline, but no effect on serotonin in this structure. The increase in preoptic noradrenaline levels appears to underlie the first fever phase and may participate in hypothalamic-pituitary-adrenocorticul axis activation. In contrast, whereas LPS had only a moderate effect on hippocampal noradrenaline, a marked increase in hippocampal extracellular serotonin levels was found. Use of the interleukin (IL)-1 receptor antagonist and the cyclooxygenase inhibitor indomethacine learned that IL-1 and prostaglandins are mediators in this response. Our data show that an endotoxin challenge results in highly differentiated changes in brain neurotransmission, probably subserving the coordinate processing of immune information in circuits involved in autonomic, neuroendocrine, and behavioral regulation.


Subject(s)
Hippocampus/physiopathology , Inflammation/physiopathology , Synaptic Transmission/physiology , Animals , Cyclooxygenase Inhibitors/pharmacology , Humans , Indomethacin/pharmacology , Injections, Intraperitoneal , Interleukin-1/pharmacology , Lipopolysaccharides/pharmacology , Male , Norepinephrine/physiology , Preoptic Area/physiopathology , Rats , Rats, Wistar , Receptors, Interleukin-1/antagonists & inhibitors , Serotonin/physiology , Synaptic Transmission/drug effects
20.
Ann N Y Acad Sci ; 840: 444-55, 1998 May 01.
Article in English | MEDLINE | ID: mdl-9629271

ABSTRACT

Presently, it is clear that the brain, immune system, and endocrine system build a complex network of interactions at various levels. Inflammation, which may be regarded as a stressful challenge, initiates apart from immunological, autonomic, and neuroendocrine responses also profound behavioral (e.g., immobility, social disinterest) changes. Key mediators herein are corticotropin-releasing hormone (CRH) and cytokines, such as interleukin-1 beta (IL-1 beta). Currently, the behavioral changes, collectively termed sickness behavior, are thought to be adaptive responses to support the body's efforts to fight the infection. Using in vivo microdialysis and biotelemetry in freely moving animals, we have studied the monoaminergic circuits in the brain implicated in the regulation of physiological and behavioral responses to a peripheral inflammatory challenge (see also chapter of Linthorst and Reul in this volume). To expand our insight into the relationship between hypersecretion of CRH and physiological and behavioral abnormalities associated with stress-related disorders, a series of experiments was conducted with long-term centrally CRH-infused rats. These rats showed reduced body weight gain, decreased food intake, elevated plasma ACTH and corticosterone levels, thymus involution and immunosuppression, but, paradoxically, enhanced IL-1 beta mRNA expression in spleen macrophages. After a peripheral endotoxic challenge on the seventh day of treatment, the CRH-infused rats produced aberrant (i.e., blunted and/or delayed) HPA axis, fever, behavioral, and hippocampal serotonergic responses. However, endotoxin-induced plasma IL-1 and IL-6 bioactivities were significantly enhanced in these animals. The data show that chronically elevated central CRH levels as occurring during chronic stress result in defective central nervous system and immune system responses to an acute (inflammatory) challenge. These observations provide evidence that chronic CRH hypersecretion is an important factor in the etiology of stress-related disorders.


Subject(s)
Brain/metabolism , Corticotropin-Releasing Hormone/metabolism , Immune System/physiology , Neurosecretory Systems/physiology , Animals , Corticotropin-Releasing Hormone/physiology , Disease Models, Animal , Inflammation/physiopathology , Male , Rats , Rats, Wistar , Stress, Physiological/physiopathology , Synaptic Transmission/physiology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...